当前位置：
X-MOL 学术
›
Arch. Med. Sci.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.
Archives of Medical Science ( IF 3.0 ) Pub Date : 2020-04-14 , DOI: 10.5114/aoms.2020.94504 Seyed Fazel Nabavi 1 , Solomon Habtemariam 2 , Emilio Clementi 3, 4 , Ioana Berindan-Neagoe 5, 6 , Cosmin Andrei Cismaru 5, 7 , Mahsa Rasekhian 8 , Maciej Banach 9, 10 , Morteza Izadi 1 , Mahdi Bagheri 1 , Mohammad Sadegh Bagheri 11 , Seyed Mohammad Nabavi 1
中文翻译：
从 SARS-CoV 和 MERS-CoV 中汲取的经验教训：FDA 批准的 Abelson 酪氨酸蛋白激酶 2 抑制剂可能有助于我们对抗 SARS-CoV-2。
更新日期：2020-04-14
Archives of Medical Science ( IF 3.0 ) Pub Date : 2020-04-14 , DOI: 10.5114/aoms.2020.94504 Seyed Fazel Nabavi 1 , Solomon Habtemariam 2 , Emilio Clementi 3, 4 , Ioana Berindan-Neagoe 5, 6 , Cosmin Andrei Cismaru 5, 7 , Mahsa Rasekhian 8 , Maciej Banach 9, 10 , Morteza Izadi 1 , Mahdi Bagheri 1 , Mohammad Sadegh Bagheri 11 , Seyed Mohammad Nabavi 1
Affiliation
中文翻译：
从 SARS-CoV 和 MERS-CoV 中汲取的经验教训：FDA 批准的 Abelson 酪氨酸蛋白激酶 2 抑制剂可能有助于我们对抗 SARS-CoV-2。
京公网安备 11010802027423号